Skip to main content

E-book

Trends shaping pharma strategy in 2026

How should pharma manufacturers strategically evolve as the industry shifts? Get expert insights from Advisory Board and Optum® Life Sciences.

How to prioritize what matters

Each year, Advisory Board and Optum® Life Sciences experts analyze the trends shaping the future for life sciences organizations. This year’s e-book spotlights 5 critical shifts that require strategic consideration in 2026. These shifts call for a more adaptive, data-informed and stakeholder-aware approach to strategy. 

Gain access to this resource

Please complete the form below to get the insights you're looking for.

Related healthcare insights

View all
Identifying Patients at Risk for Bone Fracture Within 2 Years

Case study

Identifying patients' bone fracture risk

Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.

Catalyze the Use of RWE in the Life Sciences Industry

Article

Catalyze the use of RWE in life sciences

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.

Integrated Real-World Data: The Key to Accelerating Innovation

Article

Integrated RWD: The key to accelerating innovation

To maximize the value of clinical innovations, you need dimensional, robust data. Learn about leveraging integrated cost and clinical data.